|Company Name||Issar Pharmaceuticals Pvt.Ltd.|
Plot No.80 ,Phase-1,
Hyderabad, Andhra Pradesh, India.
|Zip / Postal Code||500 073|
|Click here to email us|
Issar Pharmaceuticals Pvt. Ltd. (Issar Pharma) is a pioneer in the research and development of peptide-based health care products and their commercialization. With a state-of-the-art facility located in the industrial area of Medchal, Hyderabad, India. Issar Pharma is using the most modern and advanced automatic equipment for the development, synthesis, purification and manufacture of peptide-based drugs. The company has received permission from the Drugs Controller General (I) to manufacture first ever new molecule, a Decapeptide1, and its application as a re-pigmentation agent in the novel treatment of vitiligo. This product was released into the market in 2004 under the brand name MelgainŽ after six years of committed research.
The company has additional peptides patented for the treatment of burn wound sepsis, tumor regression, and the metastasis inhibition of different cancer diseases. These peptides are in different stages of toxicological and safety evaluations and clinical trials. Issar Pharma is planning to release individually after completion of the necessary studies and receipt of required permissions.
Below is a brief introduction of some of the projects under development by Issar Pharma. It is expected that these will all be taken up for commercialization in the near future.
|Last Updated: 2009-06-24 02:23:45|
|See something wrong?Please mail to [email protected]|